MedPath

SAM CHUN DANG PHARM Co., Ltd.

SAM CHUN DANG PHARM Co., Ltd. logo
🇰🇷South Korea
Ownership
Public
Established
1978-08-28
Employees
408
Market Cap
-
Website
http://www.scd.co.kr

A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)

Phase 3
Completed
Conditions
Wet Age-related Macular Degeneration
Neovascular Age-related Macular Degeneration
Interventions
First Posted Date
2020-07-21
Last Posted Date
2023-10-10
Lead Sponsor
Sam Chun Dang Pharm. Co. Ltd.
Target Recruit Count
576
Registration Number
NCT04480463
Locations
🇪🇸

SCD Research Site, Zaragoza, Spain

© Copyright 2025. All Rights Reserved by MedPath